JP2016526023A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016526023A5 JP2016526023A5 JP2016513077A JP2016513077A JP2016526023A5 JP 2016526023 A5 JP2016526023 A5 JP 2016526023A5 JP 2016513077 A JP2016513077 A JP 2016513077A JP 2016513077 A JP2016513077 A JP 2016513077A JP 2016526023 A5 JP2016526023 A5 JP 2016526023A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- hydrogen
- aryl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 CC(CC(*(C)[Cs])/C=I/*)S(C)*(C)N Chemical compound CC(CC(*(C)[Cs])/C=I/*)S(C)*(C)N 0.000 description 3
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361821181P | 2013-05-08 | 2013-05-08 | |
| US61/821,181 | 2013-05-08 | ||
| PCT/US2014/037342 WO2014182928A2 (en) | 2013-05-08 | 2014-05-08 | Stat6 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016526023A JP2016526023A (ja) | 2016-09-01 |
| JP2016526023A5 true JP2016526023A5 (enExample) | 2017-06-15 |
Family
ID=51867868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016513077A Withdrawn JP2016526023A (ja) | 2013-05-08 | 2014-05-08 | Ｓｔａｔ６阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9765099B2 (enExample) |
| EP (1) | EP2994143A4 (enExample) |
| JP (1) | JP2016526023A (enExample) |
| AU (1) | AU2014262621B2 (enExample) |
| CA (1) | CA2911914A1 (enExample) |
| WO (1) | WO2014182928A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3433615A1 (en) | 2016-03-21 | 2019-01-30 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Methods for diagnosis and treatment of solar lentigo |
| HRP20220479T1 (hr) | 2016-06-01 | 2022-05-27 | Athira Pharma, Inc. | Spojevi |
| US11485750B1 (en) * | 2019-04-05 | 2022-11-01 | Kymera Therapeutics, Inc. | STAT degraders and uses thereof |
| KR102444211B1 (ko) * | 2020-11-03 | 2022-09-16 | 이화여자대학교 산학협력단 | 비감염성 염증질환의 치료용 물질 스크리닝 방법 |
| US20260092078A1 (en) * | 2022-09-19 | 2026-04-02 | Kymera Therapeutics, Inc. | Stat6 degraders and uses thereof |
| TW202425965A (zh) | 2022-09-30 | 2024-07-01 | 日商科研製藥股份有限公司 | 縮環化合物及含有其之醫藥 |
| WO2025103477A1 (en) * | 2023-11-17 | 2025-05-22 | InventisBio Co., Ltd. | Compounds, preparation methods and uses thereof |
| WO2025147320A1 (en) * | 2024-01-03 | 2025-07-10 | Kymera Therapeutics, Inc. | Stat6 inhibitors and uses thereof |
| WO2025217647A1 (en) * | 2024-04-12 | 2025-10-16 | Kymera Therapeutics, Inc. | Stat6 degraders and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996016079A2 (en) * | 1994-11-24 | 1996-05-30 | Takeda Chemical Industries, Ltd | Alpha-ketoamide derivatives as cathepsin l inhibitor |
| JPH08208462A (ja) * | 1994-11-24 | 1996-08-13 | Takeda Chem Ind Ltd | カテプシンｌ阻害剤 |
| WO1997012903A1 (en) * | 1995-10-04 | 1997-04-10 | Warner-Lambert Company | Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins |
| WO1997043307A1 (en) * | 1996-05-16 | 1997-11-20 | Warner-Lambert Company | Compounds inhibiting the association of the pdgf receptor and phosphatidylinositol 3-kinase and their use |
| AU1457299A (en) * | 1997-11-12 | 1999-05-31 | Ariad Pharmaceuticals, Inc. | Novel signal transduction inhibitors, compositions containing them |
| US6426331B1 (en) * | 1998-07-08 | 2002-07-30 | Tularik Inc. | Inhibitors of STAT function |
| EP1146869A2 (en) * | 1999-01-27 | 2001-10-24 | University Of South Florida | Inhibition of stat3 signal transduction for human cancer therapy |
| GB9925677D0 (en) * | 1999-10-29 | 1999-12-29 | Pharmacia & Upjohn Spa | Use of double-quantum 1H-NMR spectroscopy for the identification of ligands interacting with target biomolecules |
| AU2001243601A1 (en) * | 2000-03-10 | 2001-09-24 | Ariad Pharmaceuticals, Inc. | Caprolactam derivatives and uses thereof |
| WO2001083517A1 (en) * | 2000-05-03 | 2001-11-08 | Tularik Inc. | Stat4 and stat6 binding dipeptide derivatives |
| FI20002216A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
| EP1518855B1 (en) | 2002-06-28 | 2011-10-26 | Astellas Pharma Inc. | Diaminopyrimidinecarboxa mide derivative |
| GB0415789D0 (en) * | 2004-07-15 | 2004-08-18 | Astrazeneca Ab | Novel combination |
| US20070010428A1 (en) | 2004-09-03 | 2007-01-11 | Mcmurray John S | Inhibitors of signal transduction and activator of transcription 3 |
| US7671058B2 (en) | 2006-06-21 | 2010-03-02 | Institute Of Medicinal Molecular Design, Inc. | N-(3,4-disubstituted phenyl) salicylamide derivatives |
| WO2008070833A2 (en) * | 2006-12-07 | 2008-06-12 | University Of South Florida | Use of sh2 stat3/stat1 peptidomimetices as anticancer drugs |
| WO2010077589A2 (en) * | 2008-12-08 | 2010-07-08 | The Regents Of The University Of Michigan Office Of Technology Transfer | Stat3 inhibitors and therapeutic methods using the same |
| US9217012B2 (en) * | 2009-04-08 | 2015-12-22 | Indiana University Research And Technology Corporation | Inhibitors of protein tyrosine phosphatases |
| US8841257B2 (en) * | 2009-04-10 | 2014-09-23 | Board Of Regents, The University Of Texas System | Inhibitors of STAT3 and uses thereof |
| US10023657B2 (en) * | 2010-10-01 | 2018-07-17 | Ludwig Institute For Cancer Research Ltd. | Reversible protein multimers, methods for their production and use |
-
2014
- 2014-05-08 EP EP14794359.1A patent/EP2994143A4/en not_active Withdrawn
- 2014-05-08 WO PCT/US2014/037342 patent/WO2014182928A2/en not_active Ceased
- 2014-05-08 AU AU2014262621A patent/AU2014262621B2/en not_active Ceased
- 2014-05-08 CA CA2911914A patent/CA2911914A1/en not_active Abandoned
- 2014-05-08 US US14/889,802 patent/US9765099B2/en not_active Expired - Fee Related
- 2014-05-08 JP JP2016513077A patent/JP2016526023A/ja not_active Withdrawn
-
2017
- 2017-08-16 US US15/678,127 patent/US10385080B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009532417A5 (enExample) | ||
| JP2017518959A5 (enExample) | ||
| EA016203B1 (ru) | Производные амина | |
| JP2015509534A5 (enExample) | ||
| JP2008515852A5 (enExample) | ||
| JP2018509438A5 (enExample) | ||
| JP2014530900A5 (enExample) | ||
| JP2024523623A (ja) | Ｎｌｒｐ３インフラマソーム阻害剤 | |
| JP2008520742A5 (enExample) | ||
| JP2016534063A5 (enExample) | ||
| JP2006524660A5 (enExample) | ||
| JP2016527220A5 (enExample) | ||
| JP2013530179A5 (enExample) | ||
| JP2016500111A5 (enExample) | ||
| JP2015520738A5 (enExample) | ||
| JP2014500861A5 (enExample) | ||
| JP2009526037A (ja) | トリアゾロピリジン化合物 | |
| JP2014534222A5 (enExample) | ||
| JP2010540593A5 (enExample) | ||
| US20220175735A1 (en) | Methods of treating pulmonary diseases and disorders | |
| EA200970158A1 (ru) | Производные хинуклидина в качестве антагонистов м3 | |
| JP2015051983A5 (enExample) | ||
| JP2017522348A5 (enExample) | ||
| JP2016510785A5 (enExample) | ||
| JP2009543795A5 (enExample) |